A functional differentiation of human neutrophil granules: generation of C5a by a specific (secondary) granule product and inactivation of C5a by azurophil (primary) granule products.
D015119:Aminocaproic Acid / Q000494:pharmacology; D002499:Centrifugation, Density Gradient; D002634:Chemotaxis, Leukocyte; D002850:Chromatography, Gel; D003182:Complement C5 / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D003165:Complement System Proteins / Q000096:biosynthesis*; D003594:Cytoplasmic Granules / Q000276:immunology*; D004492:Edetic Acid / Q000494:pharmacology; D005966:Glucuronidase / Q000032:analysis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007531:Isoflurophate / Q000494:pharmacology; D009113:Muramidase / Q000032:analysis; D009504:Neutrophils / Q000032:analysis / Q000276:immunology*; D010587:Phagocytosis; D013997:Time Factors
D003182:Complement C5; D007531:Isoflurophate; D003165:Complement System Proteins; D004492:Edetic Acid; D009113:Muramidase; D005966:Glucuronidase; D015119:Aminocaproic Acid